TAU scientists print first 3D heart using patient’s cells
In a major breakthrough, engineered heart completely matches the cellular and anatomical properties of the patient
Medicine & Health News
Engineered T Cells may be harnessed to kill solid tumor cells
There is now a multitude of therapies to treat cancer, from chemotherapy and radiation to immunotherapy and small molecule inhibitors. Chemotherapy is still the most widely used cancer treatment, but chemotherapy attacks all the rapidly dividing cells that it locates within the body, whether they’re ultimately harmful or beneficial. A new Tel Aviv University study… Read More
New antibacterial fillings from TAU may combat recurring tooth decay
Tooth decay is among the costliest and most widespread bacterial diseases. Virulent bacteria cause the acidification of tooth enamel and dentin, which, in turn, causes secondary tooth decay. A new study by Tel Aviv University researchers finds potent antibacterial capabilities in novel dental restoratives, or filling materials. According to the research, the resin-based composites, with… Read More
TAU researchers spearhead early detection of Parkinson’s disease
Parkinson’s disease is a debilitating neurodegenerative disease, affecting everything from speech, posture and gait to digestion, sleep, impulse control and cognition. Therapies exist that alleviate some symptoms of the disease, but there is still no cure for Parkinson’s, which affects close to one million Americans and 10 million people worldwide. A new Tel Aviv University… Read More
Brain alterations make it difficult for Parkinson’s disease patients to turn while walking
The ability to turn while walking is impaired among patients with Parkinson’s disease. This difficulty is also associated with freezing of gait and falls, which can have devastating medical consequences in an older population. A new Tel Aviv University study advances the understanding of turns in Parkinson’s patients, providing new insights into an everyday motor… Read More